Our analyses found that the expression levels of mRNA and protein of E2F2 in ccRCC tissues were significantly higher, and the expression of E2F2 was significantly related to the tumor stage and poor survival rate of ccRCC patients. This evidence concerns the gene E2F2 and nonpapillary renal cell carcinoma.